New Series on Personalized Medicine and the Brain (PMWC 2012)

“On aver­age, the med­ica­tions pre­scribed for brain-relat­ed con­di­tions ben­e­fit approx­i­mate­ly 50% of patients.  But which 50%?.”

“We need unam­bigu­ous bio­mark­ers that are clin­i­cal­ly rel­e­vant and scal­able at rea­son­able cost. They already exist in Can­cer.   But they do not yet exist in the Brain.” What may change that?

We are hon­ored to bring to Sharp­Brains read­ers a new series of arti­cles sum­ma­riz­ing the state of Per­son­al­ized Med­i­cine, and explor­ing its emerg­ing impact on brain health, men­tal health and brain fit­ness.  The series, writ­ten by Dr. Evian Gor­don, draws on his recent pre­sen­ta­tion at the Per­son­al­ized Med­i­cine World Con­gress (PMWC) on Jan­u­ary, 23, 2012 at Stan­ford Uni­ver­si­ty, and on the very exten­sive set of con­ver­sa­tions held dur­ing the Congress.

New Series on Per­son­al­ized Med­i­cine and the Brain:

• Mon­day, Feb­ru­ary 13th: The State of Per­son­al­ized Medicine
• Mon­day, Feb­ru­ary 20th: Chal­lenges and Oppor­tu­ni­ties of Per­son­al­ized Med­i­cine in Psychiatry
• Mon­day, Feb­ru­ary 27th: Work­ing with Health Care Indus­try Stake­hold­ers Towards Brain-based Per­son­al­ized Medicine

Dr Evian Gor­don is the Exec­u­tive Chair­man of the Brain Resource Com­pa­ny.  He ini­tial­ly drew upon  his sci­ence and med­ical back­ground to estab­lish the inter­dis­ci­pli­nary Brain Dynam­ics Cen­ter, in 1986.  Through the Brain Dynam­ics Cen­ter and its col­lab­o­ra­tive net­works, Dr Gor­don estab­lished an “inte­gra­tive neu­ro­science” approach, ground­ed in the use of stan­dard­ized meth­ods across mul­ti­ple types of data.